Encompass Health Corp
Company Stats
- Market Cap
- $12.0B
- as of Sep 30, 2026
- Enterprise Value
- $14.4B
- Shares Outstanding
- 98.1M
- Free Float
- 89.7%
Income Statement
- Revenue
- $5.9B
- Net Income
- $566.2M
- Revenue Growth, 3Y
- 10.9%
- FCF Margin, 3Y Avg
- 6.6%
- FCF Margin, Worst Year
- 5.6%
Cash Flow
- Free Cash Flow
- $439.2M
- FCF Yield
- 3.7%
- Owner FCF Yield
- 3.2%
Balance Sheet
- Cash & Equivalents
- $72.2M
- Total Debt
- $2.5B
- Net Debt
- $2.4B
Returns & Capital
- Dividends Paid
- $71.1M
- Dividend Yield
- 0.6%
- Dividend Payout, 3Y Avg
- 14.5%
- Share Repurchases
- $158.0M
- Buyback Yield, 3Y Avg
- 0.5%
- SBC, 3Y Avg
- $51.8M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $5.9B | $439.2M | 7.4% |
| FY2024 | $5.4B | $360.3M | 6.7% |
| FY2023 | $4.8B | $267.7M | 5.6% |
| FY2022 | $4.3B | $141.0M | 3.2% |
| FY2021 | $4.0B | $191.2M | 4.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 8, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back